Japan sliding down the bioventure ladder, industry warns
This article was originally published in Scrip
Executive Summary
The research-based pharma industry in Japan has issued a stark warning that the country is falling seriously behind its Asian neighbours in terms of the development of its bioventure sector and the government support that is provided to this.